These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33348248)

  • 1. Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.
    Xu H; De Silva DA; Woon FP; Ong MEH; Matchar DB; Bettger JP; Laskowitz DT; Xian Y
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105551. PubMed ID: 33348248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
    Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.
    Threlkeld ZD; Kozak B; McCoy D; Cole S; Martin C; Singh V
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1500-1505. PubMed ID: 28396187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry.
    Rodriguez N; Prasad S; Olson DM; Bandela S; Gealogo Brown G; Kwon Y; Gebreyohanns M; Jones EM; Ifejika NL; Stone S; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Goldberg MP; Birnbaum LA
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107774. PubMed ID: 38795796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital delays to stroke thrombolysis: Out of hours versus regular hours and reduction in treatment times through the creation of a 24/7 mobile thrombolysis team.
    Hebant B; Triquenot-Bagan A; Guegan-Massardier E; Ozkul-Wermester O; Maltête D
    J Neurol Sci; 2018 Sep; 392():46-50. PubMed ID: 30097154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
    Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efforts to reduce the door-to-needle time of thrombolysis in acute ischemic stroke: video-assisted therapeutic risk communication.
    Hsieh CY; Chen WF; Chen CH; Wang CY; Chen CJ; Lai EC; Chen TS
    J Formos Med Assoc; 2014 Dec; 113(12):929-33. PubMed ID: 24412584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
    Moran JL; Nakagawa K; Asai SM; Koenig MA
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.
    Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator.
    Rech MA; Bennett S; Donahey E
    Ann Pharmacother; 2017 Dec; 51(12):1084-1089. PubMed ID: 28759998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Informed Consent for Thrombolysis in Acute Ischemic Stroke.
    Comer AR; Damush TM; Torke AM; Williams LS
    J Clin Ethics; 2019; 30(4):338-346. PubMed ID: 31851625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
    Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.